 |
|
|
| |
Aesica Pharmaceuticals Ltd. has been recently granted a Certificate of Suitability by the European Directorate for the Quality of Medicines (EDQM) for its Paroxetine Hydrochloride anhydrous and hemihydrate. The certificate numbers are:
| • |
Paroxetine Hydrochloride Anhydrous: RO-CEP-2006-096-REV00 |
| • |
Paroxetine Hydrochloride Hemihydrate: RO-CEP-2006-081-REV00 |
Further details can be obtained by contacting our regulatory department:
Ashleigh Gordon
Regulatory Affairs Officer
E: ashleigh.gordon@aesica-pharma.com
<< 戻る |
|
|
|
|
|
 |
|
 |
